FDA warns device makers over unapproved claims
U.S. FDA recently released 2 warning letters to companies that it claims are marketing products for unapproved medical uses. London-based Medical Specialties of California UK has sold its Penguin Cold...
View ArticleBob Langer on drug delivery
Photo credit: Chemical Heritage Foundation Robert Langer, a pioneer in drug delivery and the most cited engineer in history, has co-founded 30 companies and treated more than 20 million patients as a...
View ArticleAbbott wins FDA nod for whole-blood molecular test for Zika
Abbott (NYSE:ABT) said today that the FDA approved its RealTime ZIKA test to detect Zika virus in whole blood for emergency use. This is the 1st molecular test made by a commercial manufacturer that...
View ArticleSurmodics raises guidance, beats Q1 earnings
Shares in Surmodics (NSDQ:SRDX) rose today after the medical device maker met expectations on Wall Street with its fiscal 2017 1st quarter results. The Eden Prairie, Minn.-based company posted profits...
View ArticleHow to go from idea to commercialization: Interview with Dr. Marie Johnson,...
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! More...
View ArticleNordisk tumbles on lowered outlook
Shares in Novo Nordisk (NYSE:NVO) fell -9% this morning after the pharmaceutical company missed expectations on Wall Street with its 4th quarter results and lowered its outlook for 2017. The Danish...
View ArticleBovie Medical tanks after failing to renew J-Plasma deal with Hologic
Bovie Medical (NYSE:BVX) saw shares plummet this week after it announced it did not extend the sales channel partnership with Hologic (NSDQ:HOLX) for its J-Plasma product, which is set to expire at the...
View ArticleJohnson & Johnson medical device chief Pruden to step down
Gary Pruden, the chairman of Johnson & Johnson‘s (NYSE:JNJ) medical devices unit, is slated to step down June 1, the healthcare giant said today. Pruden, who’s worked at J&J for 32 years, is...
View ArticleEdwards pauses CardiAQ Valve clinical trial enrollment
Edwards Lifesciences (NYSE:EW) said this week it paused enrollment in the clinical trial of its CardiAQ transcatheter mitral valve implant while it performs design validation testing on the device. The...
View ArticleMassDevice.com +5 | The top 5 medtech stories for February 2, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleQT Vascular inks Chocolate PTA distro deal with Medtronic
QT Vascular said today it inked a definitive agreement with Medtronic (NYSE:MDT) to distribute QT’s Chocolate PTA catheter for 5-years. The deal between Singapore-based QT Vascular and Fridley,...
View ArticleVisCardia closes $13m Series B, picks up Inovise Medical assets & tech
Novel heart failure device developer VisCardia said yesterday it closed a $12.5 Series B financing round and picked up the Inovise Medical’s assets and technology rights. Technology and assets from...
View ArticlePAVmed raises $1.5m in private placement
PAVmed Inc. (NSDQ:PAVMU) said today it raised $1.5 million through a private placement of Series A convertible preferred stock and Series A warrants, with funds slated to support FDA clearance of its...
View ArticleSirtex Medical shares sink on shareholder suit
Sirtex Medical (ASX:SRX) shares fell this week after announcing it is facing a suit from shareholders alleging it breached continuous disclosure obligations and engaged in misleading and deceptive...
View ArticleAlign files U.K. patent suit against ClearCorrect
Align Technology (NSDQ:ALGN) said yesterday it filed a patent infringement suit against ClearCorrect and Your Smile Direct in the UK, claiming the companies infringe patents related to its transparent...
View ArticleSecond Sight wins German reimbursement for Argus II retinal prosthesis
Second Sight Medical (NSDQ:EYES) said today it won reimbursement coverage for its Argus II epiretinal prosthesis from the German Institute for the Hospital Renumeration System, covering 15 hospitals in...
View ArticleElekta wins FDA 510(k) clearance for Venezia gynecological brachytherapy...
Elekta (STO:EKTA B) said today it won FDA 510(k) clearance for its Venezia applicator for gynecological brachytherapy, now cleared for the treatment of advanced-stage cervical cancer. The company’s...
View ArticleLantheus wins FDA nod for Definity imaging agent label update
Lantheus Medical Imaging (NSDQ:LNTH) said today it won FDA approval for a label update on its Definity imaging agent which removed a contraindication related to use in patients with a known or...
View ArticleBraeburn pulls the plug on $150m IPO, citing market conditions
Braeburn Pharmaceuticals pulled its plans for a $150 million initial public offering yesterday, citing unstable market conditions. The Princeton, N.J.-based company 1st announced plans to go public in...
View ArticleConMed slides on Q4 earnings miss
ConMed (NSDQ:CNMD) shares are off some 6% this week after the medical device company missed expectations with its 4th-quarter earnings. Utica, N.Y.-based ConMed posted a -14.6% profit decline to $6.7...
View Article